Assessing read-across – how ECHA does it
Read-across is the most commonly used alternative to testing chemicals on animals under REACH
The aim of the Read-Across Assessment Framework (RAAF) is to provide a structured approach to the scientific evaluation of read-across justifications made by registrants in their dossiers. The first publication covers read-across of human health endpoints for monostituent substances. ECHA will use it to make sure that read-across cases for human health endpoints are assessed consistently during dossier evaluation.
Registrants can use the RAAF to see the aspects of read-across justifications that ECHA considers to be crucial. This should help them to assess the quality of their own read-across cases. The RAAF is going to be further developed to also cover environmental endpoints next year.
"This is the first time that we are explaining how we evaluate read-across cases. It will help registrants to anticipate how we are going to assess their cases and thereby enable them to improve their dossiers. Of course, given the scientific complexity of the issue, this is not easy reading, but the scientists preparing read-across justifications will find it invaluable," says Geert Dancet, ECHA's Executive Director.
Read-across is the most commonly used alternative approach to filling data gaps on the effects of chemicals on humans and the environment where the test prescribed by REACH requires testing on animals. It can therefore help to avoid unnecessary testing on vertebrate animals. It works by using test results of a particular property of a substance from analogous substances to predict that property for the target substance.
Most read news
Other news from the department politics & laws
Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.